Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning

Abstract

Objective We aimed to compare cardioprotection induced by various hypoxic preconditioning (HPC) and ischemic preconditioning (IPC) protocols.

Methods Isolated rat hearts were randomly divided into 7 groups (n = 7 per group) and received 3 or 5 cycles of 3-minute ischemia or hypoxia followed by 3-minute reperfusion (IPC33 or HPC33 or IPC53 or HPC53 group), 3 cycles of 5-minute ischemia or hypoxia followed by 5-minute reperfusion (IPC35 group or HPC35 group), or 30-minute perfusion (ischemic/reperfusion group), respectively. Then all the hearts were subjected to 50-minute ischemia and 120-minute reperfusion. Cardiac function, infarct size, and coronary flow rate (CFR) were evaluated.

Results Recovery of cardiac function and CFR in IPC35, HPC35, and HPC53 groups was significantly improved as compared with I/R group (p < 0.01). There were no significant differences in cardiac function parameters between IPC35 and HPC35 groups. Consistently, infarct size was significantly reduced in IPC35, HPC35, and HPC53 groups compared with ischemic/reperfusion group.

Conclusion Multiple-cycle short duration HPC exerted cardioprotection, which was as powerful as that of IPC.

Keywords

ischemic preconditioning - hypoxic preconditioning - reperfusion injury

• References

• 1 Powers SK, Murlasits Z, Wu M, Kavazis AN. Ischemia-reperfusion-induced cardiac injury: a brief review. Med Sci Sports Exerc 2007; 39 (9) 1529-1536
• 2 De Hert SG, Preckel B, Hollmann MW, Schlack WS. Drugs mediating myocardial protection. Eur J Anaesthesiol 2009; 26 (12) 985-995
• 3 Lin JS, Chen YS, Chiang HS, Ma MC. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. J Physiol 2008; 586 (Pt 23) 5757-5769
• 4 Bautista L, Castro MJ, López-Barneo J, Castellano A. Hypoxia inducible factor-2alpha stabilization and maxi-K+ channel beta1-subunit gene repression by hypoxia in cardiac myocytes: role in preconditioning. Circ Res 2009; 104 (12) 1364-1372
• 5 Mallet RT, Ryou MG, Williams Jr AG, Howard L, Downey HF. Beta1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia. Basic Res Cardiol 2006; 101 (5) 436-446
• 6 Calmettes G, Deschodt-Arsac V, Gouspillou G , et al. Improved energy supply regulation in chronic hypoxic mouse counteracts hypoxia-induced altered cardiac energetics. PLoS ONE 2010; 5 (2) e9306
• 7 Shizukuda Y, Mallet RT, Lee SC, Downey HF. Hypoxic preconditioning of ischaemic canine myocardium. Cardiovasc Res 1992; 26 (5) 534-542
• 8 Lasley RD, Anderson GM, Mentzer Jr RM. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 1993; 27 (4) 565-570
• 9 Mei DA, Nithipatikom K, Lasley RD, Gross GJ. Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs. J Mol Cell Cardiol 1998; 30 (6) 1225-1236
• 10 Cai Z, Manalo DJ, Wei G , et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108 (1) 79-85
• 11 Zhang SX, Miller JJ, Gozal D, Wang Y. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. J Appl Physiol 2004; 96 (1) 392-397
• 12 Park AM, Nagase H, Vinod Kumar S, Suzuki YJ. Acute intermittent hypoxia activates myocardial cell survival signaling. Am J Physiol Heart Circ Physiol 2007; 292 (2) H751-H757
• 13 Pan YX, Ren AJ, Zheng J , et al. Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78. Life Sci 2007; 81 (13) 1042-1049
• 14 Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol 2008; 294 (2) H901-H908